These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 19521694)
1. Can we get the necessary clinical trials in children and avoid the unnecessary ones? Hoppu K Eur J Clin Pharmacol; 2009 Aug; 65(8):747-8. PubMed ID: 19521694 [No Abstract] [Full Text] [Related]
2. Clinical trials in children, for children. Lancet; 2006 Jun; 367(9527):1953. PubMed ID: 16782462 [No Abstract] [Full Text] [Related]
3. Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children. de Wildt SN; Knibbe CA Eur J Clin Pharmacol; 2009 Aug; 65(8):849-50; author reply 851-2. PubMed ID: 19396437 [No Abstract] [Full Text] [Related]
7. Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHS. Kim J; Ross JS; Kapczynski A JAMA; 2018 Jan; 319(1):21-22. PubMed ID: 29117365 [No Abstract] [Full Text] [Related]
8. A future for regulatory science in the European Union: the European Medicines Agency's strategy. Hines PA; Janssens R; Gonzalez-Quevedo R; Lambert AIOM; Humphreys AJ Nat Rev Drug Discov; 2020 May; 19(5):293-294. PubMed ID: 32235873 [No Abstract] [Full Text] [Related]
9. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry. O'Reilly JT Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328 [No Abstract] [Full Text] [Related]
10. Fallout from the pharma scandals: the loss of doctors' credibility? Diller L Hastings Cent Rep; 2005; 35(3):28-9. PubMed ID: 16092398 [No Abstract] [Full Text] [Related]
11. Benzodiazepines versus antidepressants for panic disorder. Keshen A Am J Psychiatry; 2004 Jul; 161(7):1311. PubMed ID: 15229078 [No Abstract] [Full Text] [Related]
13. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan]. Pflieger M; Bertram D Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054 [TBL] [Abstract][Full Text] [Related]
14. Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. Tafuri G; Trotta F; Leufkens HG; Martini N; Sagliocca L; Traversa G Eur J Clin Pharmacol; 2009 Feb; 65(2):209-16. PubMed ID: 18797857 [TBL] [Abstract][Full Text] [Related]
15. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars. Gitter DM Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759 [No Abstract] [Full Text] [Related]
16. The SSRI trials in children: disturbing implications for academic medicine. Leo J Ethical Hum Psychol Psychiatry; 2006; 8(1):29-41. PubMed ID: 16862717 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies. Walkup JT Am J Psychiatry; 2017 May; 174(5):430-437. PubMed ID: 28253735 [TBL] [Abstract][Full Text] [Related]
18. EU directive on clinical trials penalizes small sponsors. Meldolesi A Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186 [No Abstract] [Full Text] [Related]
19. Researchers left to guess at outcomes of most cancer clinical trials. Twombly R J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774 [No Abstract] [Full Text] [Related]